medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2015; 14 (4)


Detection of hepatitis B activity in HBeAg-negative carriers with normal aminotransferase levels in central Brazil

Barbosa-Júnior FV, Sanchez-Lermen RLP, Vieira KA, de Oliveira RV, Souto FJD

Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 470-476
Archivo PDF: 113.08 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Raptopoulou M, Papatheodoridis G, Antoniou A, Ketikoglou J, Tzourmakliotis D, Vasiliadis T, Manolaki N, et al. Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET Study for Chronic Hepatitis B: a multicentre Greek study. J Viral Hepat 2009; 16: 195-202.

  2. Ganem D, Prince AM. Mechanism of disease: hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004; 350: 1118-29.

  3. Fattovich G, Olivari N, Pasino M. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Gut 2008; 57: 84-90.

  4. Hadziyannis SJ. Unrevealing the natural course of the socalled “inactive HBsAg or HBV carrier state”. Hepatol Int 2007; 1: 281-4.

  5. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006; 4: 936-62.

  6. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 30: 1-36.

  7. Manno M, Cammŕ C, Schepis F, Bassi F, Gelmini R, Giannini F, Miselli F, et al. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004; 127: 756-63.

  8. Chen JD, Yang HI, Uchenna HI, You SL, Lu SN, Wang LY, Su J, et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group. Gastroenterology 2010; 138: 1747-54.

  9. Perrillo RP, Jacobson IM. Halting the natural history of hepatitis B viral infection: a paradigm shift. Semin Liver Dis 2007; 27: 3-8.

  10. Funk ML, Rosenberg DM, Lok AS. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 2002; 9: 52-61.

  11. Galizzi-Filho J, Teixeira R, Fonseca JC, Souto FJ. Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units. Hepatol Int 2010; 4: 511-5.

  12. McMahon BJ. The natural history of chronic hepatitis B virus Infection. Hepatology 2009; 49: 45-54.

  13. European Association for the Study of Liver Disease. EASL clinical practical guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-85.

  14. Villeneuve JP. The natural history of chronic hepatitis B virus infection. J Clin Virol 2005; 34: 139-42.

  15. Chu CM, Liaw YF. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol 2009; 104: 1693-9.

  16. Gigi E, Lalla T, Orphanou E, Sinakos E, Vrettou E, Raptopoulou- Gigi M. Long term follow-up of a large cohort of inactive HBsAg (+)/HBeAg (-)/ anti-HBe (+) carriers in Greece. J Gastrointestin Liver Dis 2009; 16: 19-22.

  17. Chu CM, Liaw YF. Spontaneous relapse of hepatitis in inactive HBsAg carriers from Taiwan. Hepatol Int 2007; 1: 311-5.

  18. Papatheodoridis GV, Manolakopoulos S, Liaw YF, Lok A. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. J Hepatol 2012; 57: 196-202.

  19. Martinot-Peignoux M, Boyer N, Colombat M. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002; 36: 543-6.

  20. Berk P, Korenblat K. Approach to the patient with jaundice or abnormal liver tests. In: Goldman L, Schafer A (eds.). Cecil Medicine, 24th Ed. Philadelphia: Elsevier- Saunders; 2012, p. 956-66.

  21. Zacharakis G, Koskinas J, Kotsiou S, Tzara F, Vafeiadis N, Papoutselis M, Maltezos E, et al. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study. J Hepatol 2009; 50: 1065-9.




2020     |     www.medigraphic.com